Consumer protection · from the 250-topic plan
The red-flags field manual: fifteen tells that end a GLP-1 evaluation
Everything this site has learned auditing the field, compressed into one instrument: fifteen red flags across five integrity categories — prescription, product, price, legal, and exit — each with what it looks like in the wild, why it matters, and the counter-question that confirms it. Some flags are instant disqualifiers (no prescription required; "FDA-approved" claimed on compounded product; salt forms; research-use-only labels); others are strikes that accumulate. Print it, run it against any program in ninety seconds, and let the misses do your shopping.
Category one: prescription integrity
Flag 1 — No prescription required. The instant disqualifier: a GLP-1 without a prescription is by definition an illegal sale of something, and the something is the open question. Flag 2 — The quiz that can't say no. "Evaluation" that approves everyone in ninety seconds is intake theater; ask "under what circumstances would a clinician decline me?" and watch. Flag 3 — Phantom clinicians. No nameable medical leadership, no licensure trail, prescriber questions deflected to a chat widget — a program whose doctors can't be named is a program whose doctors may not meaningfully exist.
Category two: product integrity
Flag 4 — The unnameable pharmacy. A legitimate program identifies its dispensing 503A pharmacy and state license on request; refusal is the whole answer. Verify at the state board's license lookup — two minutes, decisive. Flag 5 — Salt forms. "Semaglutide sodium/acetate" anywhere in the paperwork: the FDA has specifically flagged these as different substances — walk, per the additives audit. Flag 6 — Research-use-only anything. That label legally means not for humans; sellers using it for humans have told you their relationship with law. Flag 7 — No certificate of analysis. Real pharmacies produce batch COAs (potency, sterility, endotoxin) on request; "proprietary" is not a test result. Flag 8 — Additive-led marketing. When B12 headlines the pitch, the pitch is compensating — the additive audit explains what for.
Category three: price integrity
Flag 9 — The unquotable month seven. Ask the maintenance-dose all-in price in writing; a program that quotes only the door has answered with its business model. Flag 10 — Countdown timers on a medical checkout. Urgency machinery on a prescription decision is a values disclosure. Flag 11 — The two-line price sold as one. Membership beside medication, consult fees at checkout, shipping surprises — half-prices presented whole, decoded in the qualifier piece.
Category four: legal integrity
Flag 12 — "FDA-approved" on compounded product. A contradiction in terms and the single most reliable dishonesty marker in the field: whoever wrote it either doesn't know the law or is betting you don't. Flag 13 — Warning-letter history, unaddressed. Regulatory files are public; a seller whose parent holds a live FDA warning letter — our field has one — with no visible remediation is priced information. This site's rule: integrity files precede price files, which is why that door stays unpriced. Flag 14 — Clone-site sprawl. Identical storefronts under shuffled names and domains — the architecture of accountability avoidance, and the reason our dataset links only canonical domains.
Category five: exit integrity
Flag 15 — Silence on leaving. No findable cancellation terms, refund policy, or prepay treatment before payment: treat silence as "no," because a dispute will. The mirror test that sorts the whole field: programs confident in month nine publish the exit; programs confident only in month one hide it.
Scoring the instrument
Flags 1, 5, 6, and 12 are instant ends — no accumulation needed. Everything else: one flag is a question, two is a pattern, three is a decision. Run the manual against our own recommendations too — the audited benchmark's file passes 4, 7, 9, 11 and 15 on the record, keeps three items honestly open (named in its file), and that asymmetry between open and hidden is precisely what this manual teaches you to price. The benchmark's open file ↗
FAQ
What are the biggest red flags for online GLP-1 sellers?
Four instant disqualifiers: no prescription required, semaglutide salt forms, research-use-only labeling, and "FDA-approved" claims on compounded product. Eleven further flags accumulate across price, legal and exit integrity.
How do I verify a program's pharmacy?
Get the dispensing pharmacy's name from the program, then check the state board of pharmacy's license lookup — two minutes; refusal to name it is itself the answer.
Is a first-month discount a red flag?
Not alone — the flag is the unquotable month seven. Annualize the renewal and demand the maintenance-dose price in writing.
How many flags should end my evaluation?
Any single instant-disqualifier ends it; otherwise one flag is a question, two a pattern, three a decision.
Sources
- FDA compounding framework, salt-form communications, and public warning-letter records.
- FTC guidance on deceptive pricing, urgency tactics, and negative options.
- State pharmacy-board licensure databases; PCAB accreditation criteria.
- This site's provider files and audits — the open dataset and methodology.